BACILLUS CALMETTE-GUERIN STRAIN TICE LIVE ANTIGEN
Non-Tuberculous Mycobacteria
Johns Hopkins UniversityvaccinePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
20 Active assets in the Non-Tuberculous Mycobacteria cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Thalidomide National Center for Research Resources (NCRR) | Phase 2 | B |
Doxycycline The University of Queensland | Phase 2 | CCC |
CEFOXITIN The University of Queensland | Phase 2 | CCC |
RIFABUTIN The University of Queensland | Phase 2 | CCC |
Amoxicillin The University of Queensland | Phase 2 | CCC |
View all 21 →
Same molecule, other indications
BACILLUS CALMETTE-GUERIN STRAIN TICE LIVE ANTIGEN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →